Order Article Reprints

Zhao K, Karimi A, Kelly L, Petre E, Marinelli B, Alexander ES, Sotirchos VS, Erinjeri JP, Covey A, Sofocleous CT, et al. TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization. Current Oncology. 2025; 32(1):51. https://doi.org/10.3390/curroncol32010051

Zhao, Ken, Anita Karimi, Luke Kelly, Elena Petre, Brett Marinelli, Erica S. Alexander, Vlasios S. Sotirchos, Joseph P. Erinjeri, Anne Covey, Constantinos T. Sofocleous, and et al. 2025. "TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization" Current Oncology 32, no. 1: 51. https://doi.org/10.3390/curroncol32010051

Zhao, K., Karimi, A., Kelly, L., Petre, E., Marinelli, B., Alexander, E. S., Sotirchos, V. S., Erinjeri, J. P., Covey, A., Sofocleous, C. T., Harding, J. J., Jarnagin, W., Sigel, C., Vakiani, E., Ziv, E., & Yarmohammadi, H. (2025). TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization. Current Oncology, 32(1), 51. https://doi.org/10.3390/curroncol32010051